PL1988971T3 - Kompozycje i sposoby zachowywania funkcji mózgu - Google Patents

Kompozycje i sposoby zachowywania funkcji mózgu

Info

Publication number
PL1988971T3
PL1988971T3 PL06845640T PL06845640T PL1988971T3 PL 1988971 T3 PL1988971 T3 PL 1988971T3 PL 06845640 T PL06845640 T PL 06845640T PL 06845640 T PL06845640 T PL 06845640T PL 1988971 T3 PL1988971 T3 PL 1988971T3
Authority
PL
Poland
Prior art keywords
compositions
methods
brain function
preserving brain
preserving
Prior art date
Application number
PL06845640T
Other languages
English (en)
Inventor
Brian T. Larson
Samuel T. Henderson
Matthew A. Roberts
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL1988971T3 publication Critical patent/PL1988971T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
PL06845640T 2005-12-15 2006-12-15 Kompozycje i sposoby zachowywania funkcji mózgu PL1988971T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75139105P 2005-12-15 2005-12-15
EP06845640.9A EP1988971B1 (en) 2005-12-15 2006-12-15 Compositions and methods for preserving brain function
PCT/US2006/048077 WO2007070701A2 (en) 2005-12-15 2006-12-15 Compositions and methods for preserving brain function

Publications (1)

Publication Number Publication Date
PL1988971T3 true PL1988971T3 (pl) 2018-08-31

Family

ID=38163558

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06845640T PL1988971T3 (pl) 2005-12-15 2006-12-15 Kompozycje i sposoby zachowywania funkcji mózgu

Country Status (16)

Country Link
US (1) US20100144875A1 (pl)
EP (1) EP1988971B1 (pl)
JP (1) JP5537809B2 (pl)
CN (1) CN101405054B (pl)
AU (1) AU2006326040B2 (pl)
BR (1) BRPI0619905A2 (pl)
CA (1) CA2632550C (pl)
ES (1) ES2665744T3 (pl)
HU (1) HUE037129T2 (pl)
MX (1) MX2008007517A (pl)
NZ (1) NZ569235A (pl)
PL (1) PL1988971T3 (pl)
RU (1) RU2437656C2 (pl)
TR (1) TR201807470T4 (pl)
WO (1) WO2007070701A2 (pl)
ZA (1) ZA200806111B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
PT1292294E (pt) 2000-05-01 2009-06-01 Accera Inc Utilização de triglicéridos de cadeia média para tratamento e prevenção da doença de alzheimer
PT2500017T (pt) 2006-04-03 2017-11-14 Accera Inc Utilização de compostos cetogénicos para tratamento de comprometimento da memória associado à idade
CA3078084C (en) 2007-07-31 2023-08-15 Cerecin Inc. Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
CA2701179C (en) 2007-10-04 2021-03-16 Nestec S.A. Compositions and methods for enhancing cognitive function
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
WO2010003114A1 (en) 2008-07-03 2010-01-07 Neuera Pharmaceuticals, Inc. Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
SG195572A1 (en) * 2008-07-18 2013-12-30 Dart Neuroscience Cayman Ltd Methods and systems for evaluating memory agents
BR112012005540A2 (pt) 2009-09-11 2016-04-26 Nestec Sa composições e métodos para melhora da função cognitiva e funções relacionadas em animais
WO2011115184A1 (ja) * 2010-03-18 2011-09-22 日清オイリオグループ株式会社 生体内の蛋白質の分解抑制剤
US20150238441A1 (en) * 2012-10-05 2015-08-27 University Of Rochester Modulation of Branched Amino Acid Concentrations to Treat Metabolic Diseases
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
JP6215954B2 (ja) * 2012-12-14 2017-10-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルのための老化防止の食品
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US20170202239A1 (en) * 2014-07-17 2017-07-20 The Nisshin Oillio Group, Ltd. Baked confectionery that substantially includes no flour
EP3173089B1 (en) * 2014-07-23 2023-10-25 The Food Science Institute Foundation Agent for improving brain function and agent for preventing cognitive impairment
US20160101081A1 (en) * 2014-10-10 2016-04-14 Nestec Sa Compositions and methods for enhancing mobility or activity or treating frailty
AU2016363511A1 (en) * 2015-12-04 2018-05-10 Société des Produits Nestlé S.A. Method for improving cognition
US11000496B2 (en) 2015-12-04 2021-05-11 Societe Des Produits Nestle S.A. Medium chain triglyceride compositions
AU2017267615B2 (en) * 2016-05-20 2022-03-17 Société des Produits Nestlé S.A. Nutritional compositions for cardciac protection in companion animals
EP3463321A1 (en) * 2016-05-27 2019-04-10 Nestec S.A. Nutritional composition for treating or preventing impaired mobility
JP6908769B2 (ja) 2017-03-15 2021-07-28 セレシン・インコーポレーテッド 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する医薬組成物およびそれに関連する方法
US20190183832A1 (en) * 2017-12-20 2019-06-20 Michael Guarnieri Nutritional bolus for animals
EP3801064B1 (en) * 2018-06-07 2024-10-09 Société des Produits Nestlé S.A. Methods and compositions for increasing ketone bodies in animals
BR112020024310A2 (pt) * 2018-07-10 2021-02-23 Société des Produits Nestlé S.A. formulações de tcm para aumentar a exposição à cetona e métodos para produzir e usar tais formulações
CA3121365A1 (en) 2018-12-18 2020-06-25 Societe Des Produits Nestle S.A. Mixed triglyceriges
JP2022524491A (ja) * 2019-03-22 2022-05-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 中鎖トリグリセリド（ｍｃｔ）からのケトン産生を増加させるために食前にｍｃｔの投与を用いる方法
KR102517992B1 (ko) * 2022-05-26 2023-04-05 주식회사 에이엘 네트웍스 인지장애 및 뇌기능 개선을 위한 펫푸드 조성물 및 이의 제조 방법
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation
JPWO2025004650A1 (pl) * 2023-06-28 2025-01-02
CN117115754B (zh) * 2023-10-23 2023-12-26 贵州省种畜禽种质测定中心 基于计算机视觉的鸭舍智能化监测方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
EP0106341B1 (en) * 1982-10-20 1989-01-11 Takeda Chemical Industries, Ltd. Physiologically active substance p-23924, its production and use
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4997976A (en) * 1988-11-15 1991-03-05 Henri Brunengraber Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5190863A (en) * 1990-06-29 1993-03-02 Miles Inc. Composition for determining the presence or concentration of D-β-hydroxybutyrate
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
JP3486778B2 (ja) * 1993-04-02 2004-01-13 三菱ウェルファーマ株式会社 アルツハイマー病予防治療剤
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
DK1017379T3 (en) * 1997-03-17 2015-02-16 Btg Int Ltd Therapeutic compositions comprising ketone compounds and precursors thereof
US6093418A (en) * 1998-09-16 2000-07-25 The Iams Company Method for removing nitrogenous waste products from animals with hepatic disease
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
PT1292294E (pt) * 2000-05-01 2009-06-01 Accera Inc Utilização de triglicéridos de cadeia média para tratamento e prevenção da doença de alzheimer
ES2315350T3 (es) * 2001-01-12 2009-04-01 Waratah Pharmaceuticals Inc. Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg.
US6835759B2 (en) * 2001-08-28 2004-12-28 Basf Corporation Dual cure coating composition and processes for using the same
ES2355890T3 (es) * 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
CN1845681B (zh) * 2003-09-05 2011-12-14 希尔氏宠物营养品公司 动物用组合物
IL158139A0 (en) * 2003-09-25 2004-09-27 Enzymotec Ltd Stabilized formulations of phosphatidyl serine
US20050070602A1 (en) * 2003-09-30 2005-03-31 Jen-Wei Chiao Method of modulating immune response by administration of immuno-activation agent
WO2007001883A2 (en) * 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
CA2630990A1 (en) * 2005-12-12 2007-06-21 Hill's Pet Nutrition, Inc. Method for deriving a wellness related index for a food composition
PT2500017T (pt) * 2006-04-03 2017-11-14 Accera Inc Utilização de compostos cetogénicos para tratamento de comprometimento da memória associado à idade

Also Published As

Publication number Publication date
TR201807470T4 (tr) 2018-06-21
ES2665744T3 (es) 2018-04-27
EP1988971B1 (en) 2018-02-28
US20100144875A1 (en) 2010-06-10
CA2632550C (en) 2017-07-25
WO2007070701A3 (en) 2008-11-20
RU2008128859A (ru) 2010-01-20
AU2006326040B2 (en) 2012-02-09
WO2007070701A2 (en) 2007-06-21
CA2632550A1 (en) 2007-06-21
RU2437656C2 (ru) 2011-12-27
CN101405054B (zh) 2013-07-17
ZA200806111B (en) 2010-09-29
JP2009524587A (ja) 2009-07-02
JP5537809B2 (ja) 2014-07-02
EP1988971A2 (en) 2008-11-12
NZ569235A (en) 2011-12-22
HUE037129T2 (hu) 2018-08-28
AU2006326040A1 (en) 2007-06-21
BRPI0619905A2 (pt) 2011-10-25
CN101405054A (zh) 2009-04-08
MX2008007517A (es) 2009-03-04

Similar Documents

Publication Publication Date Title
ZA200806111B (en) Compositions and methods for preserving brain function
IL190259A0 (en) Compositions and methods comprising panax species
IL192098A (en) Preparations and Methods for Manufacturing Preparations
IL186973A0 (en) Compositions and methods for treatment for neoplasms
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
EP1959929A4 (en) COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
GB0522287D0 (en) Method and compositions
ZA200804851B (en) Compositions and methods for cell killing
IL186963A0 (en) Methods and compositions for treating pain
EP1858521A4 (en) COMPOUNDS AND COMPOSITIONS INHIBITING PROTEINS KINASES
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
IL220806A0 (en) Method and compositions for enhancing vascular access
IL184834A0 (en) Compositions and methods for the manufacture thereof
IL190239A0 (en) Pharmaceutical gallium compositions and methods
ZA200803712B (en) Methods and compositions for improving cognitive function
IL188521A0 (en) Compositions and methods for protein deaggregation
GB0525314D0 (en) Method and composition
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
ZA200608932B (en) Method and compositions for epilation
ZA200802969B (en) Composition and method
ZA200608935B (en) Methods and compositions for epilation
GB0524927D0 (en) Compositions and method
ZA200707490B (en) Methods and compositions for modulatiing vascular integrity
SG131102A1 (en) Methods for stabilizing ophthalmic compositions
ZA200805079B (en) Immunostimulatory compositions and methods